The ROE as of December 2024 (TTM) for Lisata Therapeutics, Inc. (LSTA) is -50.87%

According to Lisata Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -50.87%. This represents a change of 294.91% compared to the average of -12.88% of the last 4 quarters.

Lisata Therapeutics, Inc. (LSTA) Historical ROE (quarterly & annually)

How has LSTA ROE performed in the past?

The mean historical ROE of Lisata Therapeutics, Inc. over the last ten years is -137.70%. The current -50.87% ROE has changed -63.06% with respect to the historical average. Over the past ten years (40 quarters), LSTA's ROE was at its highest in in the March 2017 quarter at 1.18%. The ROE was at its lowest in in the December 2015 quarter at -139.99%.

Lisata Therapeutics, Inc. (LSTA) ROE by Quarter and Year

Discovering the peaks and valleys of Lisata Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Lisata Therapeutics, Inc. (LSTA) Average ROE

How has LSTA ROE performed in the past?

The current ROE of Lisata Therapeutics, Inc. (LSTA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Lisata Therapeutics, Inc. (LSTA) ROE vs. Peers

How is LSTA’s ROE compared to its peers?

Lisata Therapeutics, Inc.’s ROE is greater than Lixte Biotechnology Holdings, Inc. (-149.08%), greater than Histogen Inc. (-80.69%), greater than Imunon, Inc. (-57481.16%), less than Kineta, Inc. (934.78%), greater than Rezolute, Inc. (-69.83%), greater than Cyteir Therapeutics, Inc. (-9.44%), greater than XOMA Corporation (-33.68%), greater than Protagenic Therapeutics, Inc. (-308.96%), greater than Tempest Therapeutics, Inc. (-187.44%), greater than Pulmatrix, Inc. (-63.07%), less than Onconova Therapeutics, Inc. (619.75%), greater than Catalyst Biosciences, Inc. (-63.14%), less than Bio-Path Holdings, Inc. (2.62%), greater than Moleculin Biotech, Inc. (-165.56%), greater than Alpine Immune Sciences, Inc. (-14.86%), greater than AN2 Therapeutics, Inc. (-57.63%), greater than Ampio Pharmaceuticals, Inc. (-91.28%), greater than Monte Rosa Therapeutics, Inc. (-62.68%), less than Candel Therapeutics, Inc. (3.21%),

Build a custom stock screener for Lisata Therapeutics, Inc. (LSTA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lisata Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Lisata Therapeutics, Inc. (LSTA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Lisata Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.